tradingkey.logo

Biotechnology & Medical Research

LIST1044
457.050USD
-399.418-46.64%
Close 02/09, 16:00ETQuotes delayed by 15 min
603.23BMarket Cap
460.22MVolume
856.443Open
862.990High
460.22MVolume
306Up
228Down
69Unchanged
603.23BMarket Cap
856.468Prev. Close
456.133Low
4.30BTurnover

Biotechnology & Medical Research

457.050
-399.418-46.64%

Related Stocks

No.
Name
Price
Change
Chg %
Total Score
Time
Volume
Turnover
Market Cap
Shares
Amplitude
Volume Ratio
52wk High
52wk Low
Dividends
Div Yield
5D
10D
20D
60D
120D
250D
Year to Date
Watchlist
Ensysce Biosciences Inc
Ensysce Biosciences Inc
ENSC
0.608
+0.147
+31.77%
3.97
7.61M
1.68M
4.22K
6.94K
52.01
34.32
6.400
0.378
0.00
0.00
-14.34%
-31.30%
-40.39%
-70.20%
-71.46%
-89.52%
-33.91%
Humacyte Inc
Humacyte Inc
HUMA
1.220
+0.282
+30.02%
6.07
26.70M
24.38M
125.66M
103.00M
30.90
8.36
4.380
0.880
0.00
0.00
+19.61%
+19.61%
+4.27%
-4.69%
-32.22%
-70.46%
+27.02%
TuHURA Biosciences Inc
TuHURA Biosciences Inc
HURA
0.810
+0.181
+28.79%
3.22
4.64M
2.47M
233.42
288.14
33.35
0.86
4.770
0.410
0.00
0.00
+56.12%
+22.82%
+7.48%
-65.96%
-73.78%
-81.75%
+7.06%
4
Entera Bio Ltd
Entera Bio Ltd
ENTX
1.330
+0.290
+27.88%
6.05
528.97K
499.05K
15.82M
11.90M
32.69
2.01
3.220
1.000
0.00
0.00
+0.00%
-13.07%
-16.88%
-55.81%
-33.50%
-46.37%
-31.44%
5
Lunai Bioworks Ord Shs
Lunai Bioworks Ord Shs
LNAI
0.826
+0.163
+24.67%
--
422.56K
245.56K
14.65M
17.74M
23.52
3.60
14.000
0.630
0.00
0.00
+9.02%
-3.58%
-13.98%
-6.07%
-64.30%
-89.04%
-6.34%
6
Biomx Inc
Biomx Inc
PHGE
4.820
+0.890
+22.65%
4.05
153.28K
417.32K
4.61M
956.67K
36.89
1.55
22.057
1.500
0.00
0.00
-22.63%
+17.56%
+111.40%
-33.85%
-51.40%
-72.21%
+157.75%
7
Transcode Therapeutics Inc
Transcode Therapeutics Inc
RNAZ
10.720
+1.810
+20.31%
1.46
86.65K
525.11K
123.05
11.48
26.37
0.03
357.560
6.083
0.00
0.00
+15.27%
-13.13%
+33.83%
+18.32%
+2.10%
-96.76%
+56.95%
8
P3 Health Partners Inc
P3 Health Partners Inc
PIII
2.560
+0.410
+19.07%
5.26
119.51K
251.28K
2.13M
831.58K
27.62
0.32
12.445
1.520
0.00
0.00
+68.42%
+0.39%
-21.23%
-65.91%
-63.17%
-73.76%
-26.65%
9
Minerva Neurosciences Inc
Minerva Neurosciences Inc
NERV
5.650
+0.850
+17.71%
7.16
301.25K
995.42K
12.91M
2.28M
22.91
2.61
12.460
1.150
0.00
0.00
+20.73%
+38.82%
+26.97%
+42.32%
+131.56%
+172.95%
+40.55%
10
Immunic Inc
Immunic Inc
IMUX
0.714
+0.094
+15.16%
6.24
3.52M
1.65M
376.91K
527.89K
20.96
3.33
1.390
0.506
0.00
0.00
+9.19%
+3.13%
+7.38%
-8.45%
-27.03%
-25.63%
+33.78%

News

Chip stocks jump on AI optimism; Dow ends at record high

Cooling systems firms fall after Nvidia CEO's comments Memory and storage chipmakers hit record highs Stock valuations pricey ahead of earnings seasonS&P 500 +0.62%, Nasdaq +0.65%, Dow +0.99% By Noel Randewich Jan 6 (Reuters) - Wall Street ended higher on Tuesday, as chip stocks surged ...

ReutersWed, Jan 7
Cooling systems firms fall after Nvidia CEO's comments Memory and storage chipmakers hit record highs   Stock valuations pricey ahead of earnings seasonS&P 500 +0.62%, Nasdaq +0.65%, Dow +0.99% By Noel Randewich    Jan 6 (Reuters) - Wall Street ended higher on Tuesday, as chip stocks surged ...

Novo Nordisk's New CEO Makes $5.2B Bet on Liver Disease Treatment Through Akero Acquisition

TradingKey - Danish pharmaceutical giant Novo Nordisk announced on Thursday that it will acquire U.S. biotechnology company Akero Therapeutics for a total consideration of up to $5.2 billion.

TradingKeyFri, Oct 10
TradingKey - Danish pharmaceutical giant Novo Nordisk announced on Thursday that it will acquire U.S. biotechnology company Akero Therapeutics for a total consideration of up to $5.2 billion.

Nasdaq and S&P 500 Hit New Records, Crypto-Linked Stocks Rally

Bullish sentiment in both U.S. stocks and cryptocurrencies fueled a broad rally in crypto-related equities.

TradingKeyTue, Oct 7
Bullish sentiment in both U.S. stocks and cryptocurrencies fueled a broad rally in crypto-related equities.

MIRA Opens with a 600% Surge, Peaking at $1.73

AI token MIRA launched on Binance today, skyrocketing nearly 600% in its debut.

TradingKeyFri, Sep 26
AI token MIRA launched on Binance today, skyrocketing nearly 600% in its debut.

Pfizer Bets Big with 110% Premium to Acquire Metsera — A Lifeline in the Weight-Loss Drug Race

As Novo Nordisk and Eli Lilly dominate the weight-loss drug market — building empires from scratch — and after its own R&D setbacks, U.S. pharmaceutical giant Pfizer (PFE) is now going all-in with a doubled-premium acquisition of rising obesity drug developer Metsera.

TradingKeyMon, Sep 22
As Novo Nordisk and Eli Lilly dominate the weight-loss drug market — building empires from scratch — and after its own R&D setbacks, U.S. pharmaceutical giant Pfizer (PFE)  is now going all-in with a doubled-premium acquisition of rising obesity drug developer Metsera.

Viking Therapeutics Plunges 42% on Weight-Loss Drug Safety Fears

TradingKey - Viking Therapeutics (VKTX.US) shares tumbled over 42% on Tuesday following disappointing mid-stage trial data revealing severe side effects that shattered investor confidence.

TradingKeyWed, Aug 20
TradingKey - Viking Therapeutics (VKTX.US) shares tumbled over 42% on Tuesday following disappointing mid-stage trial data revealing severe side effects that shattered investor confidence.
KeyAI